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DECISION MAKING BY PATIENTS AWAITING KIDNEY TRANSPLANT  
Daniel A. Solomon, Nicole Rabidou, Sanjay Kulkarni, Richard Formica, Liana Fraenkel.  
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Involving patients in medical decisions by acknowledging patients’ personal values and individual 
preferences has become an important goal of providing ethical medical care.  Despite a general movement 
towards a model of shared decision-making, many patients do not fully meet their preferred role in practice.  
The decision whether or not to accept a kidney once it is offered to a patient awaiting transplant has 
historically been made predominantly by the transplant surgeon with little involvement from the patient.  
Because dialysis can provide long-term renal replacement, declining a kidney is a viable option.  Patient 
changes over time and inherent heterogeneity of donor kidneys make this an authentic decision requiring 
careful analysis of costs and benefits from the patient perspective.  The purpose of this study is to improve 
our understanding of how patients and transplant surgeons prioritize different factors when deciding 
whether or not to accept a kidney that has become available, in order to empower patients to become more 
involved in the decision-making process.  Phase I: We developed a comprehensive list of factors that 
patients might consider important through qualitative interviews with patients, and deliberation with a 
transplant surgeon (SK) and a transplant nephrologists (RF).  Phase II: We quantified the relative 
importance of each factor for patients on the transplant list and for transplant surgeons with a computerized 
survey using Maximum Differences Scaling.  We developed relative importance scores using Heirarchical 
Bayes analysis, and tested for associations between patient characteristics and relative importance scores 
using Spearman’s correlation coefficient and the Mann Whitney U test for continuous and categorical 
variables respectively.  Of the factors evaluated, patients placed the greatest value on Kidney quality, How 
closely matched you are to the kidney, and How strongly your surgeon feels you should accept the kidney.  
Relative importance of different factors did not change based on patient demographic characteristics.  
Patients who are on the waiting list longer give less importance to kidney quality (standard beta estimate -
0.23, p value 0.03) and more importance to How difficult it is for you to be matched to a donor (ie whether 
or not you are sensitized) (standard beta estimate 0.28, p value 0.01).  Surgeons placed the greatest value 
on Kidney quality, How difficult it is for the patient to be matched to a kidney (ie whether or not the patient 
is sensitized), and The age of the donor.  This pilot study suggests a role for standardized education tools to 
help empower patients to be involved in this difficult decision.  Development of decision aids can be 
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 On my ambulatory rotation during third year of medical school, I met a 56-year-
old woman named Esther who came into the office complaining of increasing fatigue, 
decreased concentration, and general aches and malaise.  She had previously been 
diagnosed with stage 4 chronic kidney disease, and her baseline creatinine, rising 
steadily, was now at 7.1.  She was well known to the medical office, visiting every two 
weeks or so with the same chronic complaints.   
 All of Esther’s doctors – her primary physician, her cardiologist and her 
nephrologist – had been advising her to consider preparing for dialysis for over a year, 
but she adamantly refused.  Dialysis was simply not an option.  I talked with Esther for 
over an hour that afternoon about each of her complaints and the effect that her disease 
was having on her life.  Each time I brought up dialysis, she steered the conversation 
away, and I followed her cue.  But for a woman who seemed to have a wonderful support 
system, with so many friends and interests, I was puzzled as to why she was so firmly 
opposed to the idea.  Out of curiosity as much as anything else I finally asked directly 
why she would not talk about dialysis. 
 Esther blushed.  “Well, I had a friend who was put under anesthesia for an 
operation, and she never woke up.  Now they tell me I need to have an operation in my 
arm before I can start dialysis, and I am too scared to go through with the surgery.”  I had 
expected a prepared speech on the burden of dialysis, the loss of three days a week, the 
inability to travel, the hassle, the frustration, the pain.  But Esther’s fear was more 
personal, more specific.   
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My encounter with Esther piqued my interest in better understanding how patients 
make decisions and the role of the physician in the decision-making process.  In honoring 
Esther’s decision to forgo dialysis, each of her doctors respected her individual 
autonomy, a principle that is paramount in this age of practicing medicine.   And yet, her 
decision was based on unfounded assumptions and an irrational fear.  By respecting her 
autonomy without probing her underlying beliefs, it seems as though her physicians 
missed an opportunity to provide expert guidance, and meaningful care. 
 What does it mean to make an informed decision?  How can doctors best 
empower patients to make their own decisions?  What responsibility do physicians have 
to explore a patient’s reasons for making a decision?  Do physicians have an obligation to 
challenge patients when they think it is in the patient’s best interest?  These questions 





Through the first half of the 20th century, paternalism was the cultural standard for 
providing medical care, with physicians playing the dominant role in the doctor-patient 
relationship and the central role in decision-making.  In this model, the physician 
diagnoses the patient’s medical condition, and selects the appropriate management to 
restore health or alleviate pain.  The doctor then provides the patient with the requisite 
information to consent to the proposed intervention (1). 
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In 1957, Michael Balint published a paper that pioneered a movement to consider 
the patient’s perspective of his own illness and to reconsider the balance of power in the 
physician-patient relationship (2). This was complemented by George Engel’s 
biopsychosocial model of care, developed in the early 1960’s.  Engel’s landmark paper, 
published in 1977, emphasized that biological disease must be considered in the 
psychosocial context of a patient’s life, and concluded that the patient’s experience of 
disease should be illuminated in the course of medical care (3,4). 
Historically, acceptance of paternalism wrested upon several basic assumptions.  
First, for most illnesses, there is a single best management strategy or treatment.  Second, 
doctors are uniformly educated about current treatment guidelines, so there is consistency 
in management of a given disease.  Third, given their rigorous training and expertise, 
doctors are best equipped to guide management when more than one option exists.  
Finally, bound by their code of ethics, doctors always act in the best interest of the patient 
(1,5). 
Technological innovation, clinical research and cultural changes in the 1980’s 
brought into question these fundamental assumptions.  Pharmaceutical and surgical 
advances amplified the element of choice in medical decision-making.  With multiple 
treatment options, there were new risks and benefits that had to be weighed, and 
physician authority to make value-based decisions was questioned (6,7).  Moreover, 
research on variations in treatment between patients with the same disease showed a 
striking lack of uniformity between different care providers (8-12).  Not only were 
physicians making value judgments on behalf of patients, their decisions lacked 
consistency.  More recent studies have further shown that physicians are poor predictors 
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of patient preferences (13, 14).  Finally, a concurrent rise in health care costs in the 
1980’s and 1990’s put additional pressure on the health care system to strive for 
uniformity and efficiency (15). 
Amidst the backdrop of the emerging biopsychosocial model of care, demand for 
evidence-based quality improvement and consistency encouraged doctors and patients 
alike to advocate a new treatment model that involved the patient in the decision making 
process (1, 5, 6, 16-18). 
Potential advantages 
 Including patients in decision-making has theoretical, ethical and practical 
benefits.  First, since only patients can truly know their own values, they are best suited to 
consider the risks and benefits of each choice in the context of their beliefs, preferences, 
and needs (19).  Furthermore, giving patients the power to make their own decisions 
fosters the bioethical principle of autonomy, which states that rational beings have the 
right to make informed decisions without coercion (20).  More specifically, ethicists have 
argued that all people have a right to determine what happens to their own bodies, and 
thus the power for patients to choose is an end in itself (21). Clinicians further believe 
that shifting the power in the doctor-patient interaction can improve the treatment 
relationship by cultivating trust and respect (22).  In sum, patient participation drives 
personalized medical care, and ideally results in increased patient knowledge, 
satisfaction, adherence to treatment, and improved outcomes (23).  
Potential disadvantages 
 Although autonomy has been embraced as a core bioethical principle and ethicists 
hail the power to choose as a self-evident right, choice has been shown to have a harmful 
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effect on some patients.  In some cases too many choices can be debilitating, and has 
been shown to increase stress and despair (24).  Further, one study showed that patients 
who preferred more choice and ownership of decisional control were ultimately less 
satisfied with outcomes, perhaps due to failed expectations (25).  When patients have 
more control over the decision-making process, they may also have a greater sense of 
culpability for adverse outcomes (26). Especially when stakes are high, some patients 
may wish for their doctor to reassume decision-making responsibility so they will not 
suffer guilt or blame themselves for a poor outcome (27). Moreover, it has been argued 
that patients may not be in the best position to value outcomes because they cannot 
anticipate how they will adapt to the consequences of their decision (28). Doctors, with 
experience and perspective, might offer better insight into functional and emotional 
outcomes for each choice.  Furthermore, even if patients are adequately informed, they 
might lack the foundational knowledge or framework to organize the costs and benefits 
and synthesize a rational decision.  Finally, including extensive discussion about patient 
preferences, values and beliefs can be a cumbersome and time-consuming model of care 
and hinders physician efficiency (29). 
Different models for patient involvement in decision-making 
 In response to the failings of paternalism, two models of decision-making 
emerged, informed and shared, both of which focus on involving patients in decisions in 
order to increase their engagement in, and ownership of their own health (29).  While 
both models are grounded in the values of patient-centered care, patient empowerment 
and evidence-based patient choice, the role of the physician differs in each model. 
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Informed decision-making is founded on the theory that the patient should be the 
sole decision-maker when there are two or more rational choices,1 and it is based on the 
fundamental assumption that physicians should never make a choice on a patient’s behalf 
(31).  The role of the physician, then, is to provide all the relevant information to the 
patient, empowering the patient to make his own choice (1).  In this model, information 
exchange is largely unidirectional from the doctor to the patient, and is mostly medical in 
nature (5).  This model assumes that patients are aware of their personal values and 
biases, and are best equipped to make a decision that balances their own beliefs with the 
relevant medical knowledge.  
 Shared decision-making entails an exchange between physician and patient and 
collaboration over the final decision (1, 5, 30, 32).  In contrast to the informed model, 
both physician and patient are involved in the decision-making process, information 
exchange is bidirectional and is both medical and personal in nature, and both physician 
and patient may express treatment preferences (5).  Proponents of the shared model 
submit that while patients are the best judge of their own values, physician perspective 
and experience may be necessary to elicit the relevant preferences.  Furthermore, if 
patients interpret information through filters of their values and beliefs and without 
objective insight into their own biases, the intended message may be lost or transformed 
(33,34). Thus, patients may not be fully equipped to make a nuanced decision without an 
exchange about personal values with the physician. 
                                                
1 It is important to note that many actions in medical care are not true decisions that require patient input 
(30).  The presence of a decision is defined by the degree of choice and certainty.  When there is only one 
treatment modality, or there is medical consensus that one treatment is certainly the best option, the 
element of choice is diminished.   E.g: for the treatment of a simple urinary tract infection, in an otherwise 
healthy patient, prescribing a course of antibiotics is not a true decision.  A decision requires two or more 
viable options – one of which may be to remain with the status quo. 
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Significance of Patient Preferences 
In a discussion of how to best serve patients, it is important to consider the actual 
perspective of real patients.  A previous study showed that patients’ conception of 
participation may differ from physicians’ or investigators’.  Patients view decision-
making as an ongoing process that exists in a broad social context (35), whereas many 
clinical studies aim to explore decisions at a discrete point in time in isolation from 
contributing social factors (36, 37).  In addition, while studies often assess patient 
preferences in isolation from their doctor’s opinions, many patients view their doctor’s 
recommendations as a key factor in decision-making.  Finally, many studies have shown 
that not all patients even want to participate in medical decision-making, or that they 
want varying amounts of control over the final decision (14, 38-41). 
Adoption of a patient decision-making model to protect patients’ rights and 
preferences raises an interesting ethical question: do patients have an obligation to make 
decisions or is it acceptable for them to ask doctors to choose on their behalf?  If we 
consider patient preferences to be most important, it seems as though we should thereby 
honor their choice to abdicate decision-making responsibility.  Some ethicists argue that 
patients have no duty to make their own decisions and thus may delegate decisional 
authority (42).  Others contend that physicians should never make a choice for a patient – 
even if the patient wants the physician to do so – because it categorically impinges on 
individual rights, and sets a standard of rewarding paternalistic behaviors amongst 
physicians (34).  A further detailed review of these ethical considerations is beyond the 
scope of the present discussion. 
Shared decision-making versus informed consent 
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In practice, the process of obtaining informed consent may be indistinguishable 
from the doctor’s role in shared decision-making, but there is an important distinction 
between the two (32).  ‘Consent’ is a legal term, rooted in the element of risk, which 
refers to a patient’s agreement to a given test, treatment, procedure or intervention.  Risk 
is inherent in medical care.  The process of obtaining consent places the burden of 
accepting that risk on the patient, and relieves the physician of liability for undesired 
outcomes.  Whereas consent is a legal principle defined by the degree of risk associated 
with an intervention, patient decision-making is an ethical principle defined by the 
element of choice or uncertainty.  It is important to note that choice is independent from 
risk and thus distinct from the legal penumbra of informed consent. 
Does patient decision-making improve outcomes? 
 While incorporating patients into decision-making may be an end in itself as 
argued above, it is important to examine how it affects quality of care as measured by 
outcomes.  Unfortunately, patient perception of control is difficult to standardize in an 
experimental model.  Even in a regulated care setting with the same doctor and 
experimental controls each patient’s assessment of decision-making control may still vary 
and thus investigators rely on patients to self-report their perception of involvement in 
management decisions (25, 43).  With this caveat, several studies show that patients who 
believe they have an active role in treatment decisions generally experience better 
outcomes (44, 45).  This is noted especially in patients with chronic diseases, such as 
diabetes and systemic lupus erythematosus, where a struggle for control seems to be 
defining.   
Strategies to improve shared decision-making 
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 Despite the compelling reasons to integrate patients into decision-making, and the 
cultural shift towards that model of care, in practice, less than half of all patients are fully 
satisfied with their role (46-48), which raises the question of how to empower patients in 
the care setting.  In a qualitative study of how best to enable patient participation, 
Fraenkel and McGraw set out five elements essential for active patient contribution: 1) 
patient knowledge, 2) explicit encouragement of patient participation, 3) appreciation of 
patient’s rights to play a role in decision-making, 4) awareness of choice, and 5) adequate 
time (23).  These factors depend heavily on communication and interventions have been 
designed to focus on improving doctors’ ability to properly engage and educate patients 
(49).  
Decision aids are information interventions, geared towards improving patient 
knowledge, that present medical information to patients in a standardized way (17).  
Ranging from interactive videos or computer programs (50) to low-technology pamphlets 
or decision flow charts (51), decision aids are designed to encourage ‘evidence-based 
decision making.’ Though studies are limited, current evidence shows that patients who 
use decision aids are more informed, and make decisions that are more in line with their 
stated preferences (52,53).  Critics of decision aids argue that each patient starts with 
different bases of knowledge, different values and different backgrounds, and information 
must be tailored to their specific needs, rather than normalized to an average patient (54). 
Arguably the most important way to empower patients to contribute to decision-
making is for the physician to create a safe environment, where patients can ask 
questions, express concerns, and voice opinions so that the doctor can provide 
appropriate information and guidance (55).  This seems to be an overarching challenge of 
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providing high quality clinical care and is independent of the academic model of 
decision-making in practice. 
 
Kidney Transplantation as a model for Shared Decision Making 
 While medical practice has come a long way from the days of 20th century 
paternalism, there remain some medical decisions in which patients remain 
predominantly passive.  Such is the case for patients awaiting a kidney transplant when 
they need to decide whether or not to accept a kidney that becomes available.  The 
following section will review the kidney allocation policy and explore the nature of this 
important decision. 
Kidney transplantation: background and policy 
 The demand for kidneys in the United States far exceeds our current supply. 
Though the number of transplants per year is steadily increasing, it is eclipsed by the 
number of new transplant candidates.  In 2008, 32,586 new candidates were added to the 
waiting list while just 16,520 transplants were performed – 10,552  from cadaver donors, 
and 5,968 from living donors.  As of December 30, 2009, there were 83,143 patients on 
the transplant waiting list (56).  The debate over organ allocation has multiple layers of 
complexity: from a moral argument – who is entitled to the organs? – to a practical 
question of social and economic policy – how can we optimize the use of this scarce 
resource? (57,58)  
The structure of the current policy is as follows.  The United Network for Organ 
Sharing (UNOS) is the governing body responsible for national organ donation, which 
oversees the activity of Organ Procurement Organizations (OPOs).  OPOs are non-profit 
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agencies responsible for the logistics of transplantation: approaching families about 
donation, coordinating recovery, preservation and transplant of organs that become 
available, and managing regional waiting lists.  There are 59 OPOs across the country, 
each responsible for a different geographic region (59). 
Organ allocation works on a point system based on the following categories: 
1. Age: 4 points for age  < 11 years; 3 points for age 11-18 years. 
2. Degree of human leukocyte antigen mismatch:2 2 points for zero-antigen 
mismatch; 1 point for one- antigen mismatch. 
3. Waiting time: patients are assigned a fraction of 1 point defined by their place on 
the waiting list.  For example, if there are 100 people on the list, the first person 
would receive 1 point; the second person would receive 99/100 points, the third 
would receive 98/100 and so on.   
4. Calculated Panel Reactive Antibody (CPRA)3: 4 points for > 80% 
5. Donation status: 4 points to patients who previously donated a vital organ or 
segment thereof (liver) within the United States. 
A few subtle details are of note.  First, there is no upper age limit.  If a surgeon 
deems a patient suitable for transplant, the candidate can be added to the waiting list.  
Second, there are no points awarded for medical urgency.  This is due to the availability 
of renal replacement therapy, dialysis, a concept I address in detail below.  Third, points 
                                                
2 Every human has a combination of six human leukocyte antigen (HLA) proteins that are expressed on 
cells throughout the body.  Degree of mismatch refers to the amount of antigens that differ between the 
patient and the donor. 
3 CPRA is a measure of the percentage of the general population that a potential recipient makes antibodies 
(is sensitized) against. Sensitization usually occurs as a consequence of pregnancy, blood transfusions, or 
previous transplantation. The greater the CPRA, the more sensitized a patient is to the general pool of 
donors, and thus the more difficult it is to find a suitable donor (60,61).  For patients who have a CPRA > 
80% it is extremely difficult to find a suitable donor, and thus patients are given an advantage for a given 
suitable kidney. 
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based on waiting time are only used to break ties among patients with equal points from 
other factors (62).  While the system is structured around a first-come-first-serve policy, 
waiting time is considered secondary to other patient characteristics and predictors of 
graft survival. 
Kidneys are offered to patients by geographic region.  Local patients are 
considered first; if no suitable recipient is identified, the kidney is offered to the regional 
list, and then finally to the national list.  The one exception is that a zero-antigen 
mismatch must be shared nationally – if there is a patient on the national waiting list that 
has a compatible blood type and shares all six human leukocyte antigens with the donor, 
that patient receives the kidney.  If there are multiple zero-antigen mismatches, the 
patient with the most points as assigned by the allocation point system receives the 
kidney (57). 
Kidneys are divided into two classes based on their donor characteristics: standard 
kidneys and expanded-criteria kidneys.  Expanded-criteria kidneys have a higher 
probability of graft failure and are distinguished by greater donor age, lower baseline 
kidney function, and presence of donor comorbidities including cardiovascular disease 
and hypertension.  At the time of enrollment on the waiting list, patients are asked if they 
would be willing to accept an expanded-criteria kidney, or if they are only interested in 
standard kidneys. 
The decision to accept a particular organ remains the privilege of the transplant 
surgeon responsible for the care of the transplant candidate.  This allows surgeons to 
exercise subjective medical judgment regarding the suitability of an organ for a particular 
patient.  Though evidence-based criteria guide surgeons’ decisions, there remains 
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controversy over standard of care regarding factors such as cold ischemia time and 
anatomic abnormalities (63,64).  If the surgeon considers the kidney appropriate for a 
given patient, the patient is contacted with the offer.  The patient is given a time limit 
(usually less than one hour) to decide whether or not to proceed with the transplant. 4 If 
the organ is refused by either the doctor or the patient, it is offered to the next appropriate 
candidate until the kidney is accepted.  A key point here is that patients who refuse a 
kidney do not lose their place on the waiting list.  While no good evidence-based data 
exists, experts predict that less that 5% of patients refuse the offer (65).  
For further information about the details of the allocation process including 
payback policies between different OPOs, and further details on CPRA, the reader is 
directed to the Organ Procurement and Transplantation allocation bylaws, found at 
http://optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp section 3.5. 
The importance of this decision  
 As discussed above, an authentic decision is defined by the presence of choice 
and uncertainty.  With the advent of dialysis, we have the technology to adequately 
replace kidney function over a long period of time.  Thus, when a patient is offered a 
kidney for transplantation there exist two medically viable options: to accept the kidney 
for transplantation, or to refuse the kidney and remain on dialysis.  An exploration of 
each choice follows. 
Accepting the kidney 
Accepting the kidney offers tremendous potential benefits: better long-term 
survival, lower risk of graft failure, better quality of life, and lower cost.  One study 
                                                
4 One predictor of graft survival and delayed graft function is cold ischemia time (63), so there is 
considerable pressure for decisions to be made quickly. 
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looking at mortality showed that long-term survival is better among patients on the 
waiting list who eventually received transplantation (66).  Another study found that 
patients who are on dialysis less than six months have a significantly greater graft 
survival at five and ten years after transplant than patients who are on dialysis longer than 
two years (67).  Finally, a critical analysis of cost and quality of life showed that patients 
who receive transplantation had a higher health-related quality of life score, and lower 
medical costs than before transplant (68). 
Renal transplantation also entails considerable risks, however, which can be 
broken into two categories: general surgical risks and risks associated with 
immunosuppression and organ rejection.  As with any common procedure, transplant 
surgery has a significant recovery period and entails risks of bleeding, infection and 
death.  The study assessing mortality in patients with ESRD found that the relative risk of 
death during the first two weeks after transplantation was 2.8 times greater than for 
patients on dialysis (66).   The major concern with any organ transplantation is the risk of 
organ rejection (either acute or chronic), which can result in symptoms and consequences 
of organ failure, further surgery to remove the offending organ, and re-initiation of 
dialysis (69).  In order to decrease the risk of rejection patients must take 
immunosuppressive therapy, which puts them at increased risk for common and 
opportunistic infections. 
Refusing the kidney  
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The second viable option is to turn down the kidney and remain on dialysis.5  
Despite the overwhelming benefits transplantation offers, there are two intrinsic elements 
of the decision that validate declining the kidney as a real option: change in patient 
characteristics over time, and heterogeneity of donor kidneys.  
Humans change over time – physically, emotionally and psychologically – and 
thus, the same person may make a different decision in two different contexts.  If a given 
patient would never accept a kidney for transplant, it would not be appropriate for him to 
be on the list at all.  There are many scenarios, however, in which a patient might want a 
kidney transplantation at some point in time, but may choose not to accept the kidney in 
the moment it becomes available.  Let us consider a patient who goes on the transplant 
list fully intending to accept any kidney that is offered to him.  The patient might have a 
second, transient illness at the time the kidney is offered, which could increase the risk of 
severe complications associated with surgery.  The patient might be dealing with a death 
or a crisis in the family, and is not emotionally prepared to undergo transplant in that 
moment.  Over time the patient may adapt to dialysis, and might perceive the decision 
differently from when he initiated dialysis treatment.  Patients perceive decision-making 
as an ongoing process that changes within different social contexts (39), and medical care 
providers must recognize the possibility for change in turn. 
The second element that validates the choice to decline a kidney is the 
heterogeneity of donor kidneys.  While surgeons presumably only offer kidneys that are 
of ‘acceptable’ quality, there is still a broad spectrum with regards to baseline function of 
kidney, risk of contracting a disease, likelihood of rejection, and expected graft survival 
                                                
5 It is notable that this decision is unique to kidney transplantation.  In the case of other vital organs such as 
heart or liver, the technology does not exist to adequately replace the function of the failing organ.  Thus, 
medical urgency removes the element of choice, as transplant is the only medically appropriate option. 
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time (70).  In addition, a zero-antigen mismatched kidney has a lower risk of rejection 
and greater overall graft survival (71,72).  Thus, a patient who is well-adjusted to dialysis 
or otherwise not anxious to receive a kidney right away, may choose to minimize the risk 
of graft rejection, or maximize the graft survival by holding out for a kidney of higher 
quality, or of a closer match. 
Should patients be involved in the decision? 
One could argue that patients should not be involved in the decision whether to 
accept or decline the kidney at all.  The factors that doctors consider when assessing a 
kidney (specific serologies, glomerular filtration rate, histological composition etc.) are 
detailed and require extensive medical training to understand.  Even more accessible 
concepts such as probability of graft failure or predicted years of graft survival are 
embedded in nuanced uncertainty.  It may be unreasonable to expect patients to make a 
decision based on medical subtleties and multiple levels of probability.   
Furthermore, as noted above, kidneys are already a scarce resource.  By 
empowering patients to become highly selective, more kidneys may ultimately be 
discarded.6  Disposal of a functional (albeit lower quality) kidney would mark a failure to 
optimize the use of a limited resource.  Doctors, the argument follows, have an obligation 
not only to the individual patient that stands in front of them, but to all patients, and must 
consider the societal impact of wasting resources (73).  Given the complexity of the 
decision, and the potential impact the decision has on society, patients should only be 
                                                
6 As discussed above, kidneys are offered to patients based on a point system as detailed above.  If the 
surgeon deems it acceptable it is offered to the patient.  If the surgeon or patient chooses to reject the 
kidney, it is offered to the next candidate on the list.  The kidney is offered down the list until it is accepted, 
until there are no suitable candidates left, or until the kidney is no longer deemed viable based on cold 
ischemia time (59). 
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allowed to decide whether or not they want a kidney at all, and should not have any 
choice with regards to the characteristics of the kidney itself. 
We contend that patients have an unassailable right to choose what happens to 
their body, especially in decisions that have the greatest impact on their health and 
quality of life.  We acknowledge the complicated nature of this decision and thus argue 
for a model of shared decision-making where both parties contribute information and 
ideas, and both parties agree on the final choice.  The challenging role of the physician 
would be to guide patients through the relevant medical details, and encourage patients to 
consider personal factors that might contribute to a better-informed decision.   
We further acknowledge the fact that there are more people on the waiting list 
than kidneys available, but the argument that rejecting more kidneys would increase 
resource scarcity fails to appreciate the heterogeneity of donor kidneys.  The simple fact 
that someone might choose to stay on dialysis rather than accept a low quality kidney 
indicates that low quality kidneys and high quality kidneys should not be considered the 
same commodity.  Though there are surely some patients who would accept any kidney, 
the argument stands that if lower quality kidneys continue to be discarded, they must not 
be in high demand and cannot be considered a scarce resource in the same category as 
high quality kidneys.  Societal impact cannot be assessed without understanding the 
demand for these organs as defined by patient preferences. 
Involving the patient in the decision  
 In spite of the established and potential benefits of kidney transplantations, the 
scenarios in which a patient might choose to decline a kidney but remain on the waitlist 
are many, and they depend on the personal values and perspectives of the individual 
18 
patient.  Organ allocation models and decision rules have previously been developed (73-
75), some even accounting for theoretical patient preferences for health outcomes.  
However, actual patient opinions, values, beliefs or perspectives about the decision 
making process have never been explicitly examined. 
We believe that there is a role for patients to be more involved in deciding 
whether or not to accept a kidney once it becomes available.  Given the significant impact 
the decision will have on the patient’s life, it is important for patients to consider the 
choices through the lens of their personal values.  We also believe that the doctor’s role 
of providing medical expertise and perspective of previous experience is essential, and so 
we advocate for the model of shared decision-making, where both parties can contribute 
their own perspective and a decision is reached together.  In order to best incorporate 
patients into the decision-making process, it is critical to understand how patients think 
about the decision, what factors they consider, how well they understand the medical 
risks and benefits, and what questions they might have about the process. 
 
 
Statement of Purpose, Hypothesis, Aims 
 The purpose of this study is to improve our understanding of how patients 
prioritize different factors when deciding whether or not to accept a kidney when it 
becomes available for transplant.  We first examine the breadth of factors that patients 
consider, how patients prioritize these factors, and the relationship between patient socio-
demographic characteristics and priorities.  We also determine how transplant surgeons 
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rank these same factors and subsequently compare patients’ and transplant surgeons’ 
priorities.  
We hypothesize that patients will prioritize the quality of the donor kidney and 
the professional opinion of the surgeon, but will also be concerned with medical and 
psychosocial factors that are specific to their own values and experience.  We expect that 
the relative importance of certain factors will vary based on socio-demographic patient 
characteristics.  Furthermore, we postulate that surgeons will prioritize the factors that 
contribute to quality of the kidney above factors that affect individual patient preferences. 
By elucidating patient preferences, it is our ultimate goal to examine how we can 





Materials and Methods 
Phase I:  The first task was to develop an exhaustive list of factors that patients might 
consider when deciding whether or not to accept a kidney. 
Patient Subjects 
After receiving HIC approval, the author was granted access to the kidney 
transplant waiting list for Yale New Haven Hospital, as well as a list of patients who have 
recently received transplants. Letters were sent to 40 subjects explaining the purpose of 
our study, and offering the choice to opt-out of a telephone interview.  Patients were 
purposely sampled to get input from both male and female subjects, and both pre-
transplant and post-transplant subjects.  We could not sample by age or race as this 
information was not available.  Patients were contacted by telephone within one week 
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after receiving the letters.  Three attempts were made to contact each patient. All patient 
interviews were conducted by the author. 
Qualitative Survey 
The author conducted in-depth individual qualitative interviews to ascertain 
which factors patients take into consideration when deciding whether or not to accept a 
specific kidney.  An additional goal was to assess the language that patients use as well as 
the language patients understand with regards to kidney transplantation in order to ensure 
that the list of factors presented to patients was readily understandable as well as 
technically accurate. 
Once contacted, patients were given one of two prompts, depending on whether 
they were pre-transplant or post-transplant.  Pre transplant: Imagine a kidney has 
become available.  Assuming it is of acceptable quality and acceptable match, what 
factors – either about the kidney or about yourself – would be important to you when 
deciding whether or not to accept the kidney? Post transplant: When your kidney 
became available, what factors were actually important to you – either about the kidney 
or about yourself – when you were deciding whether or not to accept the kidney?  
Additional prompts were used as needed to enable subjects to express their thoughts and 
opinions. 
Interviews were conducted until thematic saturation was reached.  Specifically, 
once the author conducted two interviews that yielded no new data, the surveys were 
terminated. 
List of Factors 
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 The data gathered from patient subjects were added to a Yale checklist used by 
transplant surgeons (Appendix 1).  We modified the medical jargon, and combined 
technical categories in order to develop a list that was comprehensive and could be easily 
interpreted by doctors and patients alike.  The list was reviewed by four people with 
complementary expertise: a patient-oriented researcher with expertise in medical decision 
making (LF), a transplant surgeon (SK), a transplant nephrologist (RF), and the author 
who conducted the qualitative surveys with patients (DS).  The list was pilot tested for 
comprehension.  The final list of factors is provided in Table 2.  
 
Phase II:  We quantified the relative importance that patients and surgeons assigned to 
the comprehensive set of factors derived from Phase I. 
Patients 
Patient Subjects 
Subjects were recruited from the active transplant waiting list for Yale New 
Haven Hospital (compiled May 2009).  Patients who had already received a transplant 
were excluded because the goal of the study was to critically assess how patients think 
about the decision that awaits them.  Patients who had already received a transplant 
would view the decision from a different perspective with the hindsight knowledge of 
potential success or complications. Other exclusion criteria included non-English 
speakers and impaired hearing. The interview could not be completed for 11 subjects 
because of poor comprehension. 
A letter describing the study was sent to all patients with the option to opt-out of 
the study. Patients were contacted by telephone within one week after receiving the 
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letters.  Three attempts were made to contact patients on the list.  For subjects who agreed 
to participate, but could not complete the survey at the given time, an appointment to 
complete the survey was made.  If a patient expressed interest but could not participate 
immediately, three additional attempts at contact were made.  All patient surveys were 
conducted by the author.  At the time of the survey there were 410 patients on the active 
waiting list, and 370 were contacted. 
Data Collection 
The survey consisted of a Maximum Differences Scaling (MDS) task and an 
assessment of patient demographic and clinical characteristics.  
 MDS is a task that enables subjects to assign a value to a set of factors relevant to 
a specific decision.  Based on random utility theory, MDS was developed as an 
alternative to rating and ranking tasks by Jordan Louviere in 1987 as an extension of 
Thurstone’s law of comparative judgment (76).  The strength of MDS lies in its ability to 
effectively discriminate between different items (77). 
 The task asks subjects to choose the best (or the most important) item from a 
series of sets containing different combinations of items from a master list (see Figure 1).  
Because the MDS task does not ask subjects to rate any one factor using numbers or a 
rating scale, there is no concern for scale-related bias.  MDS generates ratio data and 






Considering only these 4 factors, which do you feel is the Most Important in deciding 
whether or not to accept the kidney. 
  Most Important 
How closely matched I am with the 
donor  
The age of the donor  
How much the donor weighed  
How long I would have to wait for 
another kidney  
 
Figure 1: Example of MDS question in survey 
We chose to use MDS because it simplifies the task for the subject, it is well 
suited to phone interviews, and it is able to incorporate a large group of factors. 
The survey was administered by the author in one session, lasting between 10 and 
35 minutes. Patients were instructed to use a pen and paper to write down answer choices 
in order to aid comprehension.  After pilot testing with 9 subjects, the survey was reduced 
from 18 to 14 choice sets due to subject fatigue.  No incentive was offered to participants. 
After completing the MDS survey, the following patient characteristics were 
recorded: age, gender, race, employment, education, general health status (on a 5 point 
scale ranging from excellent to poor), time on waiting list and time on dialysis.  
Statistical Analysis  
We first report descriptive statistics of the distribution of patient characteristics. 
We then report the rank order of attributes and the mean (+SD) relative importance of 
each factor.  The mean rating scores are generated using Hierarchical Bayes (HB) 
analysis (Sawtooth Software© HB module).  HB modeling can derive stable scores at the 
individual level even though each respondent evaluates a fraction of all possible subsets 
24 
of items.  In HB modeling the averages are used to update the individual utilities in a 
number of iterations until estimates are stabilized.  After this convergence, the cycle is 
run a few thousand more times and the estimates of each iteration are saved and averaged 
(78,79).  The scores were rescaled to sum to 100 to facilitate interpretation.  HB 
programming is built into the MDS software. 
We then examine associations between subject characteristics and relative 
importance ratings using Spearman’s correlation coefficient and the Mann Whitney U 
test for continuous and categorical variables respectively. 
The independent variables we examine are: age (continuous variable), education 
(categorical variable: college education versus no college education), race (categorical 
variable: white versus non-white), gender, self-reported overall health status (categorical: 
excellent/very good versus good/fair/poor), and waiting time (continuous variable). The 
dependent factors we will assess are kidney quality (average of relative importances 
assigned to ‘overall kidney quality’ and function of ‘kidney at time of death’), ‘how 
strongly your surgeon feels you should accept the kidney,’ ‘the risk of contracting a 
disease from the donor kidney,’ and ‘how difficult it is for you to be matched to a kidney 
(i.e. whether or not you are sensitized).   
We hypothesized that age and gender would not be associated with a change in 
relative importance of any factor; that White race would be associated with greater 
importance of the surgeon’s opinion; that good health status would be associated with 
greater importance of kidney quality and the risk of contracting a disease; and that 
increased waiting time would be associated with decreased importance of kidney quality. 
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Surgeon subjects were identified through the American Society of Transplant 
Surgeons (ASTS).  Three attempts were made to contact surgeons on the list.  For 
surgeons who agreed to participate, but could not complete the survey at the given time, 
an appointment to complete the survey was made.  All surgeon surveys were conducted 
by a collaborating physician (NR). 
Data Collection 
 The survey consisted of a Maximum Differences Scaling task and an assessment 
of surgeon demographic and practice characteristics. An analogous list of factors for the 
surgeons was compiled by changing the subject of each factor from “you” to “the patient” 
appropriately, and by removing the factor ‘How strongly my transplant surgeon feels I 
should accept the kidney’ (Appendix 2).  
The MDS survey using the modified list was administered to surgeons in one 
session, lasting between 8 and 15 minutes depending on the subject. The survey consisted 
of 18 questions.  Subjects were encouraged to use a pen and paper to write down answer 
choices in order to aid comprehension. No incentive was offered to participants. 
 After completing the MDS survey, the following surgeon characteristics were 
recorded: age, gender, race, how long they have been practicing, and whether they work 
in an academic setting or a private setting.  Specific geographic and institutional data was 
collected from the ASTS website (www.asts.org). 
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Statistical Analysis 
We first report descriptive statistics of the distribution of surgeon characteristics.  
We then report the rank order of attributes and the mean (+SD) relative importance of 
each factor, using HB analysis.  Finally, we compare the patients’ and surgeons’ relative 
importances, by removing the additional factor ‘How strongly my transplant surgeon 






Phase I:   
Patient Characteristics 
 A total of 40 patients were contacted by mail: 10 male patients pre-transplant; 10 
male patients post-transplant; 10 female patients pre-transplant; 10 female patients post-
transplant.  Two subjects opted out of the study, 18 could not be reached, 6 declined to 
participate.  Fourteen patients participated in the survey: 6 male patients pre-transplant, 3 
male patients post-transplant, 3 female patients pre-transplant, and 2 female patients post-
transplant.   
List of Factors 






Table 1: Factors reported by patients 
How closely matched you are to the donor 
The overall quality of the kidney 
Whether the donor smoked cigarettes 
Whether the donor drank excessive alcohol 
Whether the donor used drugs 
The race or ethnicity of the donor 
The general health of the donor 
The risk of contracting a disease from the donor kidney 
How well you are able to tolerate dialysis 
The burden that you feel dialysis puts on your family or your caregivers 
How healthy you feel in general when the kidney becomes available 
The results of your most recent blood test 
How strongly your transplant surgeon feels that you should accept the kidney 
Whether or not your family thinks you should accept the kidney 
How long you have already been waiting on the waiting list 
How long you would have to wait for another kidney if you pass on this one 
How long the kidney is expected to last 
 
After addition of several factors from the official Yale transplant checklist, and review 
with collaborating experts, the final list of factors was developed (Table 2).  
Table 2: Final list of factors for patients 
The age of the donor 
How difficult it is for you to be matched to a kidney (i.e whether or not you are sensitized) 
How much the donor weighed 
How closely matched you are to the donor 
How the donor died 
The amount of time the kidney is outside the body before your transplant surgery 
The amount of time it would take for the kidney to start working in your body 
The overall quality of the kidney 
The function of the donor kidney at the time of death 
Whether the donor smoked cigarettes 
Whether the donor drank excessive alcohol 
Whether the donor used drugs 
The race or ethnicity of the donor 
The general health of the donor 
The risk of contracting a disease from the donor kidney 
How well you are able to tolerate dialysis 
The burden that you feel dialysis puts on your family or your caregivers 
How healthy you feel in general when the kidney becomes available 
The results of your most recent blood test 
How strongly your transplant surgeon feels that you should accept the kidney 
Whether or not your family thinks you should accept the kidney 
How long you have already been waiting on the waiting list 
How long you would have to wait for another kidney if you pass on this one 
How long the kidney is expected to last 
How old you are 
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Phase II: Patients 
Patient Characteristics 
A total of 337 patients 
were contacted by mail.  Four 
patients opted out before they 
were contacted for the study.  
141 patients could not be 
reached to complete the survey; 
70 patients declined to 
participate; 7 patients had 
already been transplanted; 11 
patients were excluded for poor 
comprehension.  A total of 104 
patients participated in the 
study. 
 Patients in the study 
ranged from age 22 to 79 with a 
mean (+SD) of 55.2 + 12.6,  
Mean time on dialysis (+SD) was 3.27 + 4.25 years, and mean time on the waiting list 




Table 3: Subjects’ Characteristics (N=104) 
Table 3: Subjects’ Characteristics (N=104) 
Characteristic n(%) 
Age, years (mean +/- SD) 55.2 +/- 12.61 
     ≥ 60 years old 48 (46.2) 
     < 60 years old 56 (53.8) 
Gender 
     Male 58 (56) 
     Female 46 (44) 
Race 
     White 68 (65.4) 
     Black 26 (25) 
     Hispanic 10 (9.6) 
Education 
     Did not finish high school 11 (10.6) 
     High School Graduate or GED 52 (50) 
     College Graduate 41 (39.4) 
Employment 
     Full Time 28 (26.9) 
     Retired 25 (24.0) 
     Disability 35 (33.7) 
Perceived Health 
     Excellent/Very Good 44 (42.3) 
     Good/Fair/Poor 60 (57.7) 
Time on Waitlist 
     ≤ 2 years 72 (69.2) 
     > 2 years 32 (30.8) 
Worried about contracting disease from donor kidney? 
     No 74 (71.1) 
     Yes 30 (28.9) 
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Relative Importance of Factors 
Patients’ importance scores, ranked from most to least important, are provided in 
Table 4.  Overall kidney quality was the most important to patients.  The surgeon’s 
opinion and the risk of contracting a disease both play a significant role in patients’ 
decision making.  The only habit of the donor that patients found important was whether 
the donor used drugs.  Despite being raised as a potential factor in Phase I, the donor’s 
race/ethnicity was of no importance to patients relative to other factors. 
If we collapse the factors into different categories based on the type of value they 
represent, we can better conceptualize how patients think about this decision.  Different 
categories of factors are presented in Table 5. 
By adding the relative importance scores of factors in each category, we can 
compare the relative importance of each category for patients (Figure 2).  Factors that 
contribute to the success of the operation were the most important to patients, but patients  



















Score (+SD) 7 
1 The overall quality of the kidney 9.83 + 0.77 
2 The function of the donor kidney at the time of death 9.27 + 1.04 
3 How closely matched you are to the donor 8.87 + 1.36 
4 How strongly your transplant surgeon feels that you should take the 
kidney 
7.71 + 2.77 
5 How long the kidney is expected to last 7.64 + 2.04 
6 The risk of contracting a disease from the donor kidney 7.49 + 2.56 
7 The general health of the donor 6.80 + 2.17 
8 How long you would have to wait for another kidney if you pass on 
this one 
5.35 + 2.61 
9 Your ability to tolerate dialysis 4.66 + 3.05 
10 How difficult it is for you to be matched to a kidney (i.e whether or 
not you are sensitized) 
4.43 + 3.11 
11 How healthy you currently feel in general 4.29 + 2.68 
12 Whether the donor used drugs 4.03 + 3.24 
13 The amount of time the kidney is outside the body before your 
transplant surgery 
3.62 + 2.04 
14 The amount of time it would take the kidney to start working in 
your body 
3.09 + 2.22 
15 How long you have already been waiting on the waiting list 2.98 + 2.44 
16 The age of the donor 2.86 + 2.37 
17 How the donor died 1.62 + 1.92 
18 The burden you feel dialysis puts on your family or caregivers 1.54 + 2.40 
19 Whether the donor drank excessive alcohol 1.24 + 2.07 
20 The results of your most recent blood tests 0.81 + 0.91 
21 Whether the donor smoked cigarettes 0.63 + 1.36 
22 How old you are 0.59 + 0.92 
23 Whether or not your family thinks you should accept the kidney 0.44 + 0.99 
24 How much the donor weighed 0.23 + 0.46 








                                                
7 The scaled importance score is a relative value score that compares the importance of 
each factor relative to all the others.  The total value of importance is set as a constant at 
100, thus all scores will sum to 100.  The relative importance scores are measures of how 




Table 5: Categories of Factors 
Kidney Quality 
     Overall kidney quality 
     Function of the donor kidney at time of death 
Transplant Outcome/Graft Survival 
     How closely matched you are to the kidney 
     How long the kidney is expected to last 
     The amount of time the kidney is outside the body before your transplant surgery 
     The amount of time it would take the kidney to start working in your body  
Risk of Communicable Disease 
     Risk of contracting a disease from the donor kidney 
Donor Factors 
     The general health of the donor 
     Whether the donor drank excessive alcohol 
     Whether the donor smoked cigarettes 
     Whether the donor used drugs 
     How much the donor weighed 
     The age of the donor 
     The race or ethnicity of the donor 
     How the donor died 
Patient Factors 
     How healthy you feel in general 
     The results of your most recent blood tests 
     How old you are 
     Your ability to tolerate dialysis 
     The burden that you feel dialysis puts on your family or caregivers 
     Whether or not your family thinks you should accept the kidney 
Time to Transplant 
     How long you would have to wait for another kidney if you pass on this one 
     How long you have already been waiting on the waiting list 
     How difficult it is for you to be matched to a donor (ie whether or not you are sensitized) 
Surgeon’s Opinion/Advice 





Figure 2: Distribution of relative importance for patients by category 
Associations between subject characteristics and relative importance scores 
 We found no association between race, education, gender or health status, and the 
relative importance that patients assigned to the quality of the donor kidney, their 
surgeon’s recommendation, the risk of contracting a disease, or how difficult it is for 
them to be matched to a kidney (whether they are sensitized). The amount of time 
patients had been on the waiting list was not associated with importance of the surgeon’s 
opinion or the risk of contracting disease, but it was associated with importance of kidney 
quality, and importance of how difficult it is for you to be matched to a kidney (Table 6).  
Specifically, waiting time was inversely related to the relative importance assigned to the 
quality of the kidney, and directly related to how difficult it is to be matched.  These 
associations did not change when we include other demographic factors into the model. 
 





Kidney Quality -0.23 0.03 
How difficult it is for you to be matched to a kidney 0.28 0.01 
*Model contains factor plus age, gender, race, deduction and health status. 
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Unsolicited comments from respondents 
 
On the surgeon’s opinion 
 
Many patients were passionate about the role of the surgeon (doctor) in their 
decision making process.  There was a stark contrast between subjects who think the 
surgeon’s opinion is most important and those who do not value or mistrust the surgeon’s 
opinion. 
It all comes down to the doctor.  If he thinks it is good enough to offer, then I am going to 
take it. (subject #14)   
 
If the surgeon recommends I take it, then I wouldn’t even question it. (subject #63)  
Sometimes I don’t trust the doctors.  If I say that something is important to me, 
they have to understand that it is important to me.  I had a kidney transplant 
about 5 years ago, and there were some complications – I started to lose my 
vision because there were pockets of fluid building up behind my eyes.  I can’t go 
blind – I am an engineer.   But the doctors didn’t listen to me…all they said was 
‘well at least you have a kidney.’  They have to understand that I don’t think 
about it that way […] I think about it so differently, so I have to be in charge of 
my own decisions.’ (subject #42) 
 
On the factor “how healthy you feel, in general, when the kidney becomes 
available” 
 
Different patients interpreted this factor differently, and chose this factor 
for different reasons.  
If I am not feeling as good, then I wouldn’t be so choosy, but if I feel as good as I 
do right now, I think I would only take the kidney if it was a perfect match. 
(subject #17) 
 
If I am feeling sick when the kidney is offered to me, I think the surgery would be 
riskier.  I want to be as healthy as possible before I go for my surgery. (subject 
#89) 
 
On accepting any kidney at all 
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There were some patients in the study who insisted they would accept any kidney 
that became available. 
I don’t care about anything at all.  I just want whatever kidney I could get.  (subject #2) 
 
I would take any kidney to give me a couple of good years with my grandchildren. I am 
already pretty old, so I would be satisfied with any good time I could have left. (subject 
#28) 
 
God will provide it to me.  And when God sends me a kidney, I would be a fool to turn 
that down. (subject #44) 
 
You are talking to the wrong person.  If there was a kidney available I would fly halfway 
around the world to get it. (subject #57) 
 
If a kidney became available, that would be the happiest day of my life.  Nothing else 
would matter except getting to the hospital in time. (subject #67) 
 
I will take any kidney to be free from dialysis.  I want to live free. (subject #83) 
 
On turning down a kidney 
Aside from the factors on the list, there were other reasons, both personal and 
philosophical, that patients offered as to why they might turn down a kidney.  Some 
samples are included below. 
I turned down a kidney in the past.  My first transplant went wrong and I was in the 
hospital for six and a half months.  I couldn’t face going through that again, so I turned 
down a kidney when it was my turn. (subject #1) 
 
I’ve thought about this very hard – what I would do when I get the phone call.  I have 
decided that one reason I would turn it down would be to give it to a child or someone 
younger than me. (subject #22) 
 
At some point in my life I will want a kidney transplant, but right now I would not accept 
any kidney.  I am on nocturnal dialysis, which runs for 8 hours each night, and I feel 
great and rested every morning.  My health is excellent[…]I feel perfectly well.  Dialysis 
is just part of my life now, like everything else – I would not risk everything that is going 
right to get a kidney transplant where everything could go wrong.  Surgery, recovery, 
immunosuppressant medications, rejection – no thank you.  I run a large company, and I 
am there everyday working hard.  One day I will be ready for a transplant, but even then 
I would only do it if it is a 6 point match – my health is too good to take on all that risk, 
so I would wait for the perfect kidney. (subject #50) 
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Phase II: Surgeons 
Surgeon Characteristics 
A total of 171 surgeons were called, 110 could not be reached, and 4 refused to 
participate in the study.  A total of 57 surgeons participated in the study.  The mean age 
(+SD) of the surgeons was 43.4 + 6.9, and they had been practicing for a mean (+SD) of 
10.0 + 7.5 years.  Fifty-four (94.8%) were male, 41 (71.9%) were White, 2 (3.5%) were 
Black, and 9 (15.8%) were Asian.  Forty-eight (84.2%) worked in an academic setting 
and 9 (15.8%) worked in a private setting. 
Relative Importance of Factors 
Surgeons’ importance scores, ranked form most to least important, are provided in 
Table 7.  Surgeons were most concerned overall kidney quality and whether or not the 
patient is sensitized.  Of note, the risk of contracting a disease was very important to them 
Drug use was the only donor habit surgeons found mildly important.  Race or ethnicity of 
the donor was not at all important to the surgeons. 
If we collapse the factors into categories as illustrated in Table 5, we can see the 
relative value of each category for surgeons in Figure 3.  Surgeons considered all 







Table 7: Relative Importance of Factors for Surgeons 
Rank Factor Scaled Importance score 
1 The overall quality of the kidney 10.05 + 0.39 
2 How difficult it is for the patient to be matched to a kidney (i.e whether 
or not the patient is sensitized) 
9.07 + 1.48 
3 The function of the donor kidney at the time of death 8.91 + 1.29 
4 The age of the donor 8.47 + 1.37 
5 The risk of contracting a disease from the donor kidney 7.71 + 2.84 
6 How long the kidney is expected to last 7.29 + 2.05 
7 The general health of the donor 7.14 + 2.46 
8 The patient’s current general health 6.87 + 2.18 
9 The amount of time the kidney is outside the body before transplant 
surgery 
6.14 + 2.88 
10 How long the patient would have to wait for another kidney if he/she 
passes on this one 
5.40 + 2.54 
11 Patient’s ability to tolerate dialysis 4.25 + 2.73 
12 Whether the donor used drugs 3.44 + 3.26 
13 How long the patient has already been waiting on the waiting list 3.24 + 2.27 
14 How the donor died 3.09 + 1.95 
15 How closely matched the patient is to the donor 2.16 + 2.17 
16 The age of the patient 2.12 + 1.11 
17 The amount of time it would take the kidney to start working in the 
patient’s body 
1.76 + 1.75 
18 Whether or not the patient’s family thinks he/she should accept the 
kidney 
1.12 + 1.45 
19 The results of the patient’s most recent blood tests 0.58 + 0.89 
20 The burden the patient feels dialysis puts on his/her family or caregivers 0.51 + 1.29 
21 How much the donor weighed 0.38 + 0.33 
22 Whether the donor smoked cigarettes 0.25 + 0.87 
23 The race or ethnicity of the donor 0.04 + 0.05 
24 Whether the donor drank excessive alcohol 0.00 + 0.00 
         
 
  
Figure 3: Distribution of relative importance for surgeons, by category 
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Comparison between patients and surgeons 
 
A comparison between the importance scores for patients (after removal of How 
strongly the surgeon feels you should accept the kidney) and surgeons is depicted in 
Table 8.  
Table 8: Comparison of Relative Importance between Patients and Surgeons 
Factor Patient 
Importance Score* 
+ SD (Rank) 
Surgeon 
Importance Score* 
+ SD (Rank) 
p value 
The overall quality of the kidney 5.22 + 0.94 (1) 5.15 + 1.26 (1) 0.84 
How difficult it is for the patient to be matched to a kidney 
(i.e whether or not the patient is sensitized) 
0.93 + 1.57 (10) 3.66 + 1.50 (2) <0.0001 
The function of the donor kidney at the time of death 4.01 + 0.98 (2) 3.25 + 0.99 (3) <0.0001 
The risk of contracting a disease from the donor kidney 2.96 + 1.66 (4) 3.05 + 2.21 (4) 0.68 
The age of the donor 0.29 + 1.43 (15) 2.71 + 1.06 (5) <0.0001 
How long the kidney is expected to last 2.68 + 1.35 (5) 2.30 + 1.02 (6) 0.06 
The general health of the donor 2.19 + 1.09 (6) 2.01 + 1.66 (7) 0.42 
The amount of time the kidney is outside the body before 
transplant surgery 
0.76 + 1.08 (12) 1.88 + 1.43 (8) <0.0001 
The patient’s current general health 0.91 + 1.50 (11) 1.80 + 1.30 (9) <0.0001 
How long the patient would have to wait for another 
kidney if he/she passes on this one 
1.58 + 1.51 (7) 1.31 + 1.45 (10) 0.28 
Patient’s ability to tolerate dialysis 1.16 + 1.81 (8) 0.65 + 1.41 (11) 0.13 
How long the patient has already been waiting on the 
waiting list 
0.31 + 1.42 (13) 0.21 + 1.10 (12) 0.64 
How the donor died -1.25 + 1.14 (17) 0.21 + 1.02 (13) <0.0001 
Whether the donor used drugs 1.13 + 1.68 (9) -0.07 + 2.11 (14) <0.0001 
The age of the patient -2.41 + 1.41 (20) -0.36 + 0.69 (15)  
The amount of time it would take the kidney to start 
working in the patient’s body 
0.29 + 1.20 (14) -0.75 + 1.21 (16) <0.0001 
How closely matched the patient is to the donor 3.71 + 1.33 (3) -0.83 + 1.32 (17) <0.0001 
Whether or not the patient’s family thinks he/she should 
accept the kidney 
-2.67 +1.24 (21) -2.09 + 1.21 (18) 0.001 
The results of the patient’s most recent blood tests -1.56 +0.86 (19) -2.20 + 0.93 (19) <0.0001 
How much the donor weighed -3.22 +1.14 (23) -2.49 + 0.55 (20) <0.0001 
The burden the patient feels dialysis puts on his/her family 
or caregivers 
-1.14 + 1.47 (16) -2.81 + 1.33 (21) <0.0001 
Whether the donor smoked cigarettes -4.01+ 2.19 (22) -3.67 + 0.99 (22) 0.005 
Whether the donor drank excessive alcohol -1.54 + 1.56 (18) -6.43 + 0.43 (23) <0.0001 
The race or ethnicity of the donor -10.33 +0.45 (24) -6.48 + 0.81 (24) <0.0001 
*These are mean raw scores, not rescaled to 100 
In general, the patient and surgeon rankings were strikingly similar, from top to 
bottom.  They share five of the first seven factors in common, and seven of the last eight.  
Both patients and surgeons thought kidney quality was most important, and gave 
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statistically comparable importance to that factor (p=0.84).  Patients and surgeons both 
gave the same high value to the risk of contracting a disease from the donor kidney 
(p=0.68).  Neither patients nor surgeons gave value to the race of the donor, or to the 
drinking or smoking habits of the donor.  Overall, patients and doctors seem to be 
concerned with the same factors, and they seem to consider the same factors unimportant. 
Though the similarities between doctors and patients were many, there were also 
several factors to which surgeons and patients gave different value.  We will highlight a 
few important differences to note.  Surgeons were more concerned than patients about the 
age of the donor:  fifth most important with importance score 2.71 versus 15th most 
important with importance score 0.29 (p<0.0001).  Surgeons gave more importance to 
how difficult it is for a patient to be matched to a kidney (ie whether or not the patient is 
sensitized):  second most important, with importance score 3.66 versus 10th most 
important with relative importance of 0.93 (p<0.0001).  Finally, patients gave more 
importance to how closely you are matched: third most important with relative 




 In this pilot study, we used Maximum Differences Scaling to measure the 
different factors patients and surgeons consider when deciding whether or not to accept a 
kidney transplant.  This is the first study, to our knowledge, that explores the patient’s 
perspective of this unique decision. 
We found that patients were most concerned with kidney quality and factors that 
affect transplant outcome or graft survival.  Our quantitative data show that the surgeon’s 
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opinion was very important to patients in general, but there were patients who expressed 
mistrust in doctors and preferred to be the primary decision maker.  Our hypotheses that 
variations in patient demographics would be associated with changes in the importance of 
different factors were largely disproved; only increased time on the waiting list was 
associated with significant changes in factor importance.  Furthermore, we found that 
surgeons value similar factors to patients, with kidney quality being the most important. 
Discussion of patient preferences 
One aim of the present study was to examine potential associations between 
patient characteristics and the importance of different factors.  Previous studies of patient 
perspectives of treatment decisions have shown variation in preferences based on age, 
socioeconomic status and education (80).  One prior study on disparity of access to 
kidney transplantation found that patients’ treatment preferences and outcome 
expectations differed by race with Black patients significantly less likely than White 
patients to want a transplant, and less likely to be certain of that preference (81).  
In our study, we found no association between race, education, age or gender and 
how patients ranked any of the factors.  This is encouraging for two reasons.  First, it is a 
good measure of quality control, as it suggests the survey design, format and length were 
equally accessible to subjects regardless of their demographic characteristics or level of 
education.  It supports the validity of this study, and it reinforces the concept that MDS 
can be used effectively for investigational or educational purposes (77).  Second, while 
we are sensitive to the importance of individual patient variability, there were no 
conflicting preferences of different patient subgroups.  Thus, a common approach to care 
and education can be used for all patients. 
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Time on the waiting list was associated with two notable changes in relative 
importance of different factors.  First, increased waiting time was independently 
associated with decreased importance of kidney quality.  In other words, the longer 
patients were waiting, the less they cared about the quality of the kidney they receive.  A 
previous study has shown that both physical and mental quality of life decline over time 
on dialysis (82).  As quality of life declines, patients likely become more anxious for 
change and would favor the risk of transplantation with a lower quality kidney.  Further, 
patients who wait longer might tire of dialysis and the waiting process and become more 
willing to accept any kidney regardless of quality.   
 Increased waiting time was also associated with a greater importance of How 
difficult it is for you to be matched to a kidney (ie whether or not you are sensitized).  We 
suspect, in this case, that increased time on the waiting list is acting as a marker for 
patients who are actually sensitized.  Patients who are sensitized have a longer mean 
waiting time, because it is more difficult for them to find an appropriate match (60), and 
are far more likely to value this factor because they understand its implications on their 
chance of being offered a kidney.  In order to test this hypothesis, we would have to 
collect subject calculated panel reactive antibody (CPRA) percent.8   
Given that older patients make up most of the population on the extended-criteria 
donor list, it is interesting to note that increased age was not associated with a decreased 
importance of kidney quality in our study. 9  One potential explanation for why this 
                                                
8 Recall, CPRA is a measure of the percentage of the general population that a potential recipient makes 
antibodies (is sensitized) against.  For patients who have a CPRA > 80% it is extremely difficult to find a 
suitable donor, and thus patients are given an advantage for a given suitable kidney. 
9 Expanded-criteria donor (ECD) kidneys are distinguished by greater donor age, lower baseline kidney 
function, and presence of donor comorbidities including cardiovascular disease and hypertension and have 
a higher probability of graft failure.  Most of the patients on the ECD list are older than 60-years-old or 
41 
discrepancy was not elucidated lies in our study is that the survey assessed relative value 
of factors.  While older patients may be willing to take a lower quality kidney, it was still 
more important than any other factor on the list.  As opposed to increased waiting time 
where the importance of other factors increased as the importance of kidney quality 
decreased, there were no other factors more important for older subjects, so its relative 
value remained constant. 
Patients who would accept any kidney 
Some respondents insisted they would accept any kidney that becomes available, 
as evidenced by comments during the surveys.  These patients believe that remaining on 
dialysis is not an acceptable option.  The most common explanation patients offered for 
this view was the overwhelming burden of dialysis, but other reasons included religious 
beliefs, and advanced stage of life.  One previous study of women with early stage breast 
cancer showed that many patients do not acknowledge “doing nothing” as a real option 
(83).  We suspect that some patients might similarly equate refusing the kidney with 
“doing nothing,” which could devalue the option to stay on dialysis. 
Understanding that some patients do not perceive this to be a real decision is 
significant for two reasons.  First, while such patients may still value some factors more 
highly than others, quantitative analysis on the relative importance of the different factors 
is relevant only in the context of a real decision with two or more acceptable choices.  
The MDS task is only pertinent if preferences actually inform the subjects’ ultimate 
decisions – i.e. if the subjects are willing to make trade-offs.  Second, this finding 
emphasizes the importance of the physician’s educational role at the beginning of the 
                                                                                                                                            
diabetics greater than 40-years-old, and thus there is strong evidence to suggest older patients will accept 
lower quality kidneys.  
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care-providing relationship.  Patients must be armed with the knowledge to understand 
the real nature of the decision so they can properly grapple with the choices from a 
personal standpoint. 
Surgeon Preferences 
 The vast majority of the surgeon subjects were white males, consistent with the 
demographics of transplant surgeons in general.  Given the homogeneity of our sample, 
we did not have enough respondents to parse out variations in relative importance based 
on race, age or gender.  That being said, the general profile of surgeons is changing with 
more women and more minorities entering the field.  It will be interesting to see if 
preferences and practice differ across demographics as the population of transplant 
surgeons becomes more diverse. 
Comparison of Patients and Surgeons  
Similarities between patients and surgeons 
It is worth emphasizing the significant overlap between the factors the surgeons 
and patients considered important.  This suggests either that patients and surgeons value 
similar factors at baseline, or that there already exists good communication between care 
providers and patients with regards to medical risks and benefits as well as patient 
preferences.  The notion that doctors and patients seem to consider the same types of 
factors important is encouraging because it indicates that there is common ground on 
which to build educational materials such as decision aids to streamline communication.  
It is particularly interesting to note that both patients and surgeons are very 
concerned with the risk of contracting a disease from the donor kidney, even though, with 
current screening methods, the risk is extremely low – estimates for contracting a disease 
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from a donor kidney range from low risk at 1:315,000 to high risk at 1:10,000 (84).  This 
finding is likely due to patients’ and surgeons’ heightened perception of risk in the 
context of decisional power.  A study from the core decision-making literature 
demonstrated that increased perception of control, defined as ‘command over outcome,’ 
is associated with a decreased perception of risk, whereas increased perception of 
volition, defined as ‘command over exposure to risk itself,’ is associated with increased 
perception of risk (85).  Applied to our study, this concept suggests that transplant 
surgeons would underestimate intra-operative risks they can control, such as bleeding or 
damage to a surrounding organ, and overestimate the risks to which they willingly expose 
the patient that they cannot control, such as the risk of contracting a disease.   
A recent study, looking at patient responsibility in decision-making, builds on the 
concept of perceived risk to show that greater responsibility over decision-making may 
decrease the likelihood of patients’ willingness to accept risky procedures (26).  In the 
present study, although the risk of contracting a disease is very low, patients are highly 
sensitive to the risk when they bear decision-making responsibility.   
The perception of disease transmission is paramount to both patients and doctors 
alike.  Our findings illustrate the importance for surgeons to be aware of their own 
perspectives and biases, and the demand for patient education about risk of disease 
transmission. 
Differences between patients and surgeons 
Although patients and surgeons significantly overlap in their priorities, sharing 
five of the top seven factors, there were several noteworthy differences.  First, transplant 
surgeons are much more concerned than patients about the age of the donor.  It has been 
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well established that kidneys from donors greater than 56 years old have a significantly 
decreased graft survival at 1 and 2 years post transplant.  Because this is likely due to 
decreased functional reserve at the time of transplant, increased donor age is a predictor 
for decreased graft survival (72,86,87).  While surgeons are familiar with the current 
literature on importance of donor age, patients might have attached less importance 
because they did not view age of donor as a marker of quality.  
The next notable difference is that doctors give greater importance to how difficult 
it is for a patient to be matched to a kidney (i.e. whether or not the patient is sensitized).  
The difference may be explained as follows.  All surgeons understand the concept of 
sensitization and the difficulty for sensitized patients to find a proper match.  They 
further know that the UNOS allocation policy gives preference to sensitized patients.  
This uniform understanding is evidenced by the consistency with which surgeons favored 
this answer, reflected in the small standard deviation of relative importance, 1.48.  In 
contrast, patient understanding of this concept varied.  While patients who are sensitized 
are likely to understand the implications of sensitization on the chances of finding a 
suitable donor, those who are not sensitized are less likely to be aware of this concept and 
to use it in their decision-making.  This disparity is reflected in the large standard 
deviation of relative importance, 3.11, which suggests there was a broad distribution of 
importance scores for this factor.  This is an example of the evaluability hypothesis, that 
predicts one factor might be undervalued because it is more difficult to evaluate, or is less 
accessible to the subject (88). 
A third important distinction is that patients valued how closely you are matched 
to the donor much greater than surgeons.  This discrepancy likely indicates patients’ 
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belief that proximity of match is a predictor of transplant outcome or risk of rejection.  
While there is a substantial graft survival benefit for zero-antigen and one-antigen 
mismatched kidneys (71), there is only a minimal survival difference associated with a 
small change in proximity of match thereafter.  One study showed that mean graft 
survival of 1-4 antigen mismatch (9.6 years) was only slightly greater than mean survival 
of 5-6 antigen mismatch (8.6 years) (72).  Surgeons would likely prefer a fully matched 
transplant, but they found degree of match less important. 
These differences between patients and surgeons point to important areas for 
further patient education. 
Understanding the Patient Perspective 
As we try to define discrete factors that patients take into account, it is important 
to question how patients actually make decisions.  Decision-making and preferences are 
deeply rooted in broader concepts of health, illness and disease as well as transient 
emotional states.   
We each view our choices from the perspective of our individual frames of 
reference.  Let us consider the factor, “How healthy you feel, in general, when the kidney 
becomes available.”  As evidenced by patient reflections during the survey, patients 
interpret this choice differently.  Some patients would be less likely to accept the kidney 
if they are feeling well because they would rather stay the course in their current state 
than undergo a procedure that entails its own risks and complications.  Other patients 
would be more likely to accept the kidney if they are feeling well, under the assumption 
that surgery would be riskier if they have another, transient illness at the time of 
transplant.  
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On the surface, these are simply two different, equally rational, interpretations of 
the given factor, how healthy you feel, in general.  If we dig deeper and explore the 
meaning of these interpretations, the disparity seems to stem from a fundamental 
difference in patients’ perceptions of their chronic renal failure.  The patients in the first 
group understand how healthy you feel to define their present location on the overarching 
course of their kidney disease.  At one point, renal failure may have a minimal, 
acceptable effect on the patient’s health; at another, the burden of disease may be 
unacceptable.  Patients in the second group understand how healthy you feel to define 
presence or absence of an illness separate from their chronic kidney disease.  This 
understanding of the term ‘healthy’ is independent from the underlying illness.   For these 
patients, chronic renal failure is intrinsically unacceptable and does not contribute to their 
conception of how healthy you feel in the moment.  If we follow this example through to 
the point where the patient must choose whether or not to accept a kidney that has 
become available, we see that the final decision may be driven as much by this personal 
abstraction of health as by discrete factors about the donor or the kidney.  This is a 
concrete example of how preferences are formed in the context of our individual frames 
of reference, and are intimately embedded in our definitions of health, disease and illness. 
Furthermore, patients are likely overwhelmed by emotion – excitement, fear, hope 
– when they are offered a kidney and these emotions may be more operative in their 
thinking than discrete objective factors.  While patients may objectively evaluate factors 
in the context of our survey, it is difficult to recreate the emotional charge of the actual 
decision.   
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Even if there are broader forces that drive patient decision-making, there is still a 
great deal to learn from our study of discrete factors, as we should encourage decisions 
made upon objective values rather than subjective emotional states.  Patients are more 
likely to be satisfied with their decision and less likely to regret the decision if it is 
reasoned through rationally.  By elucidating the factors patients deem important, we are 
able to understand what is important to patients before the decision point, and we can 
thus prepare them better to make a sound decision.  If we address these discrete, objective 
factors in the planning stages through educational tools or extra sessions with a patient 
advocate or educator, we can prepare patients to make an informed decision driven by 
established values rather than transient emotions. 
Strengths 
The strength of our study is the use of Maximum Differences Scaling.  The two 
most common approaches to prioritizing factors are ranking analysis and rating scales, 
and we submit that MDS is preferable to both these techniques for the purpose of our 
study.  Ranking tasks are limited by the number of factors subjects can keep in mind, 
whereas MDS is able to handle an exhaustive list of factors.  MDS also has several 
important advantages over rating scales in the context of our study: 
• The question format is easy to understand, and respondents from diverse socio-
demographic backgrounds have been shown to be able to provide reliable data. 
• It demonstrates greater discrimination among items and is better able to discriminate 
between segments of the study population. Thus, MDS produces more accurate 
estimates of individual as well as group-level preferences.  
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• Because each task generates more information about respondents’ preferences, MDS 
is more efficient than rating scales.  
• Scale-related response bias is not a concern because respondents make choices 
instead of indicating their preference using rating scales.  This is an extremely 
valuable property for cross-cultural research studies, where subjects across different 
cultures may systematically differ in the way they use rating scales. 
Limitations 
 The greatest limitation of this study is the small sample size of subjects, both 
patients and surgeons.  The small number of subjects makes it difficult to determine 
differences between subject groups, and the low response rate limits the generalizability 
of our findings.   
Future Directions 
Development of Decision Aid 
 In keeping with the objective to empower patient involvement in the decision- 
making process, we recommend the development of a standardized decision aid that 
would be introduced to patients as soon as they are placed on the transplant waiting list. 
Such an educational tool would provide information and guidance to help patients better 
understand the nature of the decision, and enable them to think critically about their 
choices.  Preparing transplant candidates with this information early in the process would 
allow patients to consider the weighty risks and benefits over time, and empower them to 
ask questions before a kidney becomes available.  Our study shows that patients awaiting 
transplant do not differ based on demographic characteristics, and thus a standardized 
decision aid would be appropriate for all transplant candidates. While each patient’s 
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needs must certainly be addressed individually, information tools can be developed to 
meet the general needs of the transplant population.  This resource would improve 
patients’ funds of knowledge and enrich communication with physicians. 
 MDS could be used as the model for a decision-task because it is simple for 
patients to use, and it would introduce patients to the factors they should think about and 
discuss with their doctors.  This model would provide a framework for patients to get 
involved in making an informed decision. 
Research Question: Preemptive Kidney Transplant 
We interviewed a subset of subjects who are on the transplant waiting list but are 
not on dialysis.  This is consistent with a trend in kidney transplantation called 
“preemptive kidney transplantation.”  The concept is that the patients with kidney failure 
are placed on the transplant waiting list before they reach end stage disease, so they can 
receive a transplant before requiring dialysis.  This is an attractive option for many 
patients as it avoids the morbidity of dialysis and dialysis-related procedures such as 
fistula placement (89).  Patients would not have to cut back from their employment to 
take on dialysis, and the overall cost to the patient of managing the kidney disease would 
be decreased.  Furthermore, studies have found that preemptive transplant may decrease 
the rate of delayed graft function and improve patient and graft survival (90,91).  This is a 
strategy that is being implemented more commonly in an effort to improve patient quality 
of life, as well as health outcomes, and is championed by some as the optimal mode of 
renal replacement therapy (92). 
 Despite the benefits of this treatment model, there are also theoretical detriments. 
First, in a field where there is already a limit on resources, giving kidneys to patients 
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before the need for dialysis would mark a failure to maximize native kidney function. 
Further, studies have shown that there is a slightly higher rejection risk in preemptive 
transplant recipients, possibly because they lack the immunosuppressive effects of 
uremia, which could help prevent early rejection (89).   
Wide-spread adoption of preemptive transplantation strategy also raises several 
ethical issues.  First, patients who are already waiting on dialysis waiting would be 
disadvantaged because they would be part of a much larger pool, and thus more likely to 
be competing for kidneys with more people with the same HLA-genotype (92). Second, a 
study of prevalence of preemptive transplant showed that race, ethnicity and education 
are all independently associated with preemptive transplantation, suggesting this practice 
currently puts some patients at a disadvantage, and contributes to existing transplant 
disparity (89). 
 With regards to the present study, the practice of preemptive transplant raises 
interesting questions about decision-making.  Instead of choosing between accepting the 
kidney versus staying on dialysis, the patients must decide whether to take the kidney 
now, versus taking the chance that another kidney will become available before they 
require dialysis. If a match comes up relatively quickly, or the patient’s kidney function 
declines very slowly, it is conceivable that a kidney would be available for transplant 
before it is medically necessary, or even before the patient feels unwell.  An interesting 
follow up study, given the increasing popularity of preemptive transplants, would be to 
compare the relative importance of factors for patients already on dialysis against those 




In an effort to understand how patients make difficult medical decisions, and to 
define the appropriate role of the physician in the decision-making process, I drew 
several personal conclusions from this study. 
As I was working on this project, aimed at examining and defining patient 
preferences, I gained an appreciation for the complex nature of preferences themselves. 
They are shaped by contextual factors such as culture, upbringing and education, and 
they reflect distinct personal characteristics such as values and beliefs.  On a deeper level, 
however, they are embedded in our emotions and our personal concept of health and 
illness.  
So how does this developing concept of patient preferences inform my own 
understanding of shared decision-making?  First, it emphasizes the power of the 
relationship and communication between doctors and patients.  It heightens the goal of 
providing a safe environment for patients to ask questions and to express and explore 
their own perspectives, values and understandings.  Doctors have the incredible power, 
owing to their knowledge and perspective, to guide patients along in their thinking, to 
challenge patients to reflect on their preferences, and to empower patients to make 
informed decisions. 
Second, it highlights, for me, the inherent value of the process of asking questions 
about patient preferences.  My goal in caring for patients as a future physician is to 
relieve suffering through mindful, patient-centered care.  The act of thinking about how 
to empower patients, or how to define patient preferences, or how to understand patient 
perceptions, naturally brings the patient into the focus of medical care.  While the task of 
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understanding the patient’s perspective through the lens of each individual’s world-view 
may be impossible, by asking these questions we may be able to do better.  More 
importantly, perhaps, by searching for answers to these questions, we can more clearly 
define our own values and priorities, and reinforce our commitment to serving others to 















































 Tcell CDC crossmatch 
 Bcell CDC crossmatch 
 Tcell Flow crossmatch 
 Bcell Flow crossmatch 
 Presence of donor specific antibody 
 Recipient PRA 
Cause of Death 
Mechanism of injury 
Extended donor kidney 
Donor after cardiac death 
Anticipated total cold ischemia time 
Cardiac arrest/downtime 
CPR administered 





 % Glomerulosclerosis 
 Interstitial fibrosis (1+ to 4+) 
 Tubular atrophy (1+ to 4+) 
 Vessel hyalinosis (1+ to 4+) 
Kidney Anatomy 
 Aortic/renal artery disease 
 Renal mass NOS 
 Complex arterial/venous anatomy 
 Lower pole artery not reconstructable 
Social History 




 Presence of Hematuria 
 Presence of Proteinuia 





 Anti-HIV I/II 





 History of Diabetes 
 History of Kidney Stones or other Kidney Diseases 
 History of Hypertension 
 History of Coronary Artery Disease 
 History of Peripheral Vascular Disease 
 History of Malignancy 
 History of Surgeries 
 Gastrointestinal disease 
 Cigarette use (>20 pack years) 
 Heay alcohol use (2+ drinks/day) 
 IV drug use 
Vital Signs 
 Significant hypotension 
 Urine output 
 Hypoxia 
 Core Body Temperature 



























Factors for Surgeons 
The age of the donor 
How difficult it is for the patient to be matched to a kidney (i.e whether or not the patient is sensitized) 
How much the donor weighed 
How closely matched the patient is to the donor 
How the donor died 
The amount of time the kidney is outside the body before your transplant surgery 
The amount of time it would take for the kidney to start working in the patient’s body 
The overall quality of the kidney 
The function of the donor kidney at the time of death 
Whether the donor smoked cigarettes 
Whether the donor drank excessive alcohol 
Whether the donor used drugs 
The race or ethnicity of the donor 
The general health of the donor 
The risk of contracting a disease from the donor kidney 
The patient’s ability to tolerate dialysis 
The burden the patient feels dialysis puts on his/her family or caregivers 
How healthy the patient currently feels in general 
The results of the patient’s most recent blood test 
Whether or not the patient’s family thinks he/she should accept the kidney 
How long the patient has already been waiting on the waiting list 
How long the patient would have to wait for another kidney if he/she passes on this one 
How long the kidney is expected to last 
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